The Impact of Policy on Pharmaceuticals and Pricing Transparency

This chapter explores the effects of the Inflation Reduction Act on the pharmaceutical industry, particularly its potential to deter investment in small molecule drugs. The discussion also critiques pharmacy benefits managers and advocates for greater transparency and reform to improve drug pricing and access for patients.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app